Earth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD Patents

Hollywood, Florida, UNITED STATES

Hollywood, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotechnology company that operates in the fields of hemp cannabinoid, nutraceutical, pharmaceutical, and medical device research and development, announces that it has signed an agreement with the Centre de Développement Bioalimentaire du Québec (CDBQ), a major force in the agro-food industry in Canada. 

CDBQ to take ETST products from prototype to mass production

Based in La Pocatière, Quebec, CDBQ specializes in helping companies develop the processes needed to take a prototype agro-food or nutraceutical product to industrial-scale production for the marketplace. Partnering with CDBQ gives ETST access to the wide range of services, technologies, and expertise needed to complete the final stage of product development.

ETST is anxious to take advantage of CDBQ’s bio-food incubator, a 30,000 square foot $10 million facility that houses seven separate factories that boast specialized, cutting-edge equipment and technology.

The first project with CDBQ is the development of the manufacturing processes for the three already-prototyped provisional CBD based nutraceutical products that ETST has in the pipeline updated in April

Two of these products will be delivered in capsule form (nutraceutical), while the third is a liquid condiment that is added to day-to-day foods. Once those products have been delivered, ETST will begin working with CDBQ’s renowned R&D group to realize new ideas and products.

Working with CDBQ, ETST will develop manufacturing processes that incorporate Best Practices and meet all norms and regulatory requirements for production; while maintaining high standards of quality, production efficiency, and cost-effectiveness.

“We are proceeding with our stated plan to establish our product line and build a steady and sustainable revenue stream with our current CBD product line.” said Dr. Aubé. “Our products will have a proven track record of safety and success even before we can launch them in North America.” The company has several distribution agreements and joint ventures to develop new products and new markets currently in negotiations, which will be announced as they are finalized.

In the continuing work to develop new pharmaceutical and nutraceutical drugs, ETST is in negotiations to sponsor a study of generic CBD-improved pharmaceutical drugs. In addition, ETST is in negotiations with a Canadian university to launch a pre-clinical study with the goal of developing a breast cancer treatment; and a separate partnership with a group of physicians to conduct clinical studies to help individuals with epileptic and non-epileptic seizures. These projects are expected to be active by Q4 2017.

President, Director, & COO, Nickolas S. Tabraue concludes with, “ I’m very proud and pleased with our R&D and company progress. Thanks to Dr. Michel Aube and our amazing advisory board team of scientists and doctors, we are now on the cusp of having our three unique CBD patent pending products launched in the very near future. Most importantly, we are committed to further studies with a new university to continue developing treatments to help people in need. We at Earth Science Tech strive to reach out and help. All the lives we have positively changed motivate us to continue our research and make a difference. More exciting updates to be released very soon as they progress and are finalized.”

About Earth Science Tech, Inc. (ETST): Earth Science Tech has the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the world's best supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research performed along with the University of Central Oklahoma and DV Biologics, proves we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil. To learn more please visit:

View ETST's accomplishments and reports on its High-Grade CBD Hemp Oil: (here)

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly-owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes, and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to helping grow ETST in the medical and pharmaceutical industry.
To learn more please visit:

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly-owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics’ mission is to help change the healthcare landscape by introducing proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.
To learn more please visit:

About KannaBidioiD: KannaBidioid, Inc. is a wholly-owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused on manufacturing and distributing vapes/e-liquids and gummy edibles formulated by it's unique Kanna and CBD formula in the recreational market. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus, and help with nicotine addiction based on their properties.
Website coming soon:

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. The FDA has not evaluated the validity or truthfulness of these claims; therefore, we encourage you to review published researches relating to the benefits and properties of CBD hemp oils and other CBD products.

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


Contact Data